Stacy Lindborg Insider Profile

4 Followers
Stacy Lindborg, Co- CEO at Brainstorm Cell Therapeutics, holds 264.17K shares in Imunon (Ticker: IMNN), holds 423.44K shares in Brainstorm Cell Therapeutics (Ticker: BCLI). Most recently, Stacy Lindborg Bought ― shares of Imunon on Aug 16, 2024 for an estimated value of 24.50K.
tipranks
Stacy Lindborg

Stacy Lindborg
Brainstorm Cell Therapeutics (BCLI)
Co- CEO

Ranked #82,118 out of 99,218 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-49.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$970K
73.32%
26.68%
A breakdown of Stacy Lindborg's holdings

Insider Roles

Brainstorm Cell Therapeutics
(BCLI)
Co- CEO
Imunon
(IMNN)
President & CEO, Director
Roles that Stacy Lindborg holds in companies

Most Profitable Insider Trade

Stock:
Imunon
(IMNN)
Rating:Informative Buy
Date:Aug 16, 2024 - Today
Return:-16.60%
The most profitable trade made by Stacy Lindborg

Stacy Lindborg's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Brainstorm Cell Therapeutics
Mar 13, 2024
Co- CEO
Uninformative Buy
$711.37K
Imunon
Aug 16, 2024
President & CEO, Director
Informative Buy
24.50K
$258.88K
List of latest transactions for each holding click on a transaction to see Stacy Lindborg's performance on stock

Stacy Lindborg insider profile FAQ

What is the percentage of profitable transactions made by Stacy Lindborg?
The percentage of profitable transactions made by Stacy Lindborg is 0%.
    What is the average return per transaction made by Stacy Lindborg?
    The average return per transaction made by Stacy Lindborg is -49.50%.
      What stocks does Stacy Lindborg hold?
      Stacy Lindborg holds: BCLI, IMNN stocks.
        What was Stacy Lindborg’s latest transaction?
        Stacy Lindborg latest transaction was an Informative Buy of $24.50K.
          What was Stacy Lindborg's most profitable transaction?
          Stacy Lindborg’s most profitable transaction was an Informative Buy of IMNN stock on August 16, 2024. The return on the trade was -16.60%.
            What is Stacy Lindborg's role in Brainstorm Cell Therapeutics?
            Stacy Lindborg's role in Brainstorm Cell Therapeutics is Co- CEO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.